bispecific antibody Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (2)

Phase 1/2 (2)
Phase 2 (1)

Interventional (3)

Akeso (2)
BeiGene (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadmetastatic adenocarcinoma

I am/have/hadhepatocellular carcinoma

I am/have/hadmajor surgery

I am/have/hadmetastatic cervical carcinoma

I am/have/haderbb2

I am/have/hadformalin-fixed paraffin-embedded

I am/have/hadsquamous cell carcinoma

I am/have/hadcancer therapy

I am/have/hadpd-l1

I am/have/hadcervical carcinoma

I am/have/hadadenocarcinoma

I am/have/hadmeasurable disease

I am/have/hadadenosquamous cell carcinoma of the cervix

I am/have/hadadenocarcinoma of the breast

I am/have/hadcancer

I am/have/hadejection fraction

I am/have/hadadenocarcinoma of the gastroesophageal junction

I am/have/hadcytotoxic chemotherapy

I am/have/hadmetastasis

I am/have/hadgastric adenocarcinoma

added new label for I am/have/had

I am looking for

I am looking forlenvatinib

I am looking forattenuated vaccines

I am looking forhuman epidermal growth factor

I am looking foroxaliplatin

I am looking forerbb2

I am looking forimmunosuppressive

I am looking forgrowth factor

I am looking forepidermal growth factor

I am looking forcorticosteroids

I am looking fortislelizumab

I am looking forbevacizumab

I am looking forcapecitabine

I am looking forbispecific antibody

I am looking fordocetaxel

I am looking forprednisone

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab

The purpose of the study is to assess the safety, tolerability and preliminary antitumor activity of ZW25 in combination with docetaxel in participants with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, and ZW25 in combination with tislelizumab and chemotherapy in participants with HER2-positive gastric/gastroesophageal Junction (GEJ) adenocarcinoma

metastatic adenocarcinoma

erbb2

cancer therapy

adenocarcinoma

measurable disease

0 views
16 Feb, 2024
12 locations

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

carcinoma

attenuated vaccines

major surgery

metastatic cervical carcinoma

formalin-fixed paraffin-embedded

0 views
16 Feb, 2024
20 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

An open-label multi-center phase Ib/II study to evaluate the efficacy and safety of anti-PD-1/CTLA-4 bispecific antibody AK104 plus lenvatinib as the first-line therapy for patients with advanced hepatocellular carcinoma.

lenvatinib

carcinoma

hepatocellular carcinoma

measurable disease

0 views
05 Aug, 2020